Ovarian Cancer Incidence (1989-1991) and Mortality (1954-1993) in the Netherlands
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Objective: To examine ovarian cancer incidence and mortal ity in the N etherlands, and to relate trends in mortality to changes in parity and use of oral contraceptives.
Methods: Age-standardized and age-specific incidence and mortality rates are presented using incidence data from the N etherlands Cancer Registry, 1989-1991, and mortality data from the N etherlands Central Bureau of Statistics, 1954 Statistics, -1993 .
Results: In the period 1989-1991, age-standardized inci dence of ovarian cancer was 14.9 per 105 woman-years. The majority (89%) of these tumors had an epithelial origin. Two-thirds of all newly diagnosed ovarian cancers already showed extension to the pelvis or beyond at diagnosis. From the period 1954-1958 to 1969-1973 , age-standardized mortal ity rates increased from 10.6 to 13.1 per 105 woman-years. Thereafter, a decline was noted to 11.4 per 105 woman-years in the period 1989 "1993. Age-specific mortality rates showed a pattern of rising mortality in the elderly, whereas mortality in the younger age categories was declining. The num ber of live births has declined gradually, and oral contraceptive use has increased.
Conclusion'. Incidence of ovarian cancer is high in the N etherlands, but comparable to other countries in north western Europe and North America. Mortality rates are rising in the elderly and declining in the young. Further research is needed concerning the effects of oral contracep tives, fertility drugs, and hormone replacement therapy on the incidence and mortality of ovarian cancer. (Obstet Gy necol 1996; 88:387-93) Ovarian cancer is one of the most frequent malignancies in women and shows a wide geographic variation in incidence. Highest risks are observed among the more affluent populations in northwestern Europe and North America, with a 1-2% cumulative risk of being diag nosed with ovarian cancer before the age of 75.1,2 The majority of the ovarian cancers remain unnoticed until disease has spread beyond the ovary. Survival rates have increased since the introduction of more aggres sive treatment modalities in the late 1970s (extensive surgery followed by platinum-based chemotherapy regimens), but are still extremely poor. Reported stagespecific 5-year survival rates range from approximately 80% for localized disease to less than 10 % in case of distant métastasés,2"7 At present, ovarian cancer re mains the most lethal gynecologic malignancy in the western world. 7 Extensive research has been done in the etiology of ovarian cancer, but so far the pathogenesis is only partially understood. 8 The key findings in this field are the identification of genetic factors related to ovarian cancer and the important role of the hormonal system in the etiologic pathway.5,8"13 Fathaila (Incessant ovula tion: A factor in ovarian neoplasia [letter] . Lancet 1971; ii:163) suggested that the disruption of the ovarian epithelium at ovulation may represent the key step leading to malignant transformation. Consequently, fewer ovulations during a woman's lifetime might lead to a lower risk of ovarian malignancy. The protective effect of increased painty, breast feeding, and use of oral contraceptives (OC) found in several studies is consis tent with this hypothesis of "incessant ovulation/78"13 Oral contraceptives were introduced in the 1960s and gained widespread use thereafter. Consequently, the potential protective effect of OCs could result in a decline in the occurrence of ovarian cancer. Evidence of such a decreasing trend in incidence and/or mortality is already found in several countries around the world.1,2,14-23 However, large geographic variations ex ist, and the major decrease is still to come because most women who used OCs are only now reaching high-risk Incidence rale (per 100,000 woman-years) Figure 1 . Age-specific ovarian can cer incidence in the Netherlands, 1989-1991. Cum. = cumulative.
5-Year age category ages for developing ovarian cancer. 24 The aim of this study was to investigate the incidence and mortality of ovarian cancer in the Netherlands, Because national incidence data were available only recently, the empha sis will be on the analysis of mortality data.
Materials and Methods
Numbers of newly diagnosed ovarian cancers for the period 1989-1991 were derived from the Netherlands Cancer Registry.25 For ovarian cancer, we used Interna tional Classification of Diseases (ICD) for Oncology code 183.0.26 Data regarding morphology and lateral ization were derived directly from the registry records. The Netherlands Cancer Registry records International Federation of Gynecology and Obstetrics (FIGO) stage from 1992 onward. Therefore, the FIGO stage of all diagnosed cases had to be assigned retrospectively by using the clinical and pathologic tumor node metastasis classification. 27 Data regarding the number of women with ovarian cancer as the underlying cause of death as well as the age-and calendar year-specific numbers of Dutch fe males were abstracted from publications of the Nether Age-specific incidence rates are presented for the 388 Koper et al Ovarian Cancer in the Netherlands years 1989-1991 combined. All rates are expressed in 10s woman-years. In addition to the crude incidence rate, the age-standardized incidence rate using the European Standard Population30 and the cumulative risk of ovarian cancer before the age of 75 are presented. Age-specific mortality rates are presented by 5-year calendar periods (1954-1958 to 1989-1993) . Agestandardized rates (all ages) are presented for the same periods.
Results
Since necessary requirements for FIGO staging were not met. Almost one-third of all patients (1177 cases) had bilat eral disease. The right-to-left ratio was 1.12, indicating that right-sided tumors occurred slightly more often. In 15.3% of all cases, no lateralization was specified.
increased Table 2) . When age-specific mortality rates are considered, a more diverse pattern in mortality rates can be observed (Table 2, Figure 2 ). Whereas the younger age groups showed relatively stable or even slightly declining mortality rates after the period 1969-1973, the older age groups showed an increasing trend in mortality. This is illustrated in Figure 2 (for clarity, age-specific mortality rates are presented by 10 -year age groups).
Discussion
The age-standardized incidence of ovarian cancer in the Netherlands is in the same order of magnitude as described for Sweden, Denmark, Germany, and Canad a.14'16/18,19 The distribution of morphology, FIGO stage, and lateralization of all ovarian cancer cases in the Netherlands is also comparable to those reported in other studies.21,31 The slightly higher occurrence of ovarian cancer in the right ovary is probably due to chance because it was not found in a much larger study of unilateral ovarian cancers in the United States.31 Age-specific rates are climbing with age. Several studies have described a pattern of declining incidence rates over time in younger ages, whereas an increase in incidence is described in older ages.18"21,21 Because the Netherlands Cancer Registry has been operational only since 1989, it was not possible to investigate the trend in incidence rates in our data. Instead, we investigated whether such a trend could be observed in mortality data available for the Netherlands over a much longer period. Ovarian cancer mortality in the Netherlands was relatively stable. However, age-specific mortality rates are rising in the older age-groups and are declin ing in the young. Several other studies, dealing with data from other countries, described a similar pattern in age-specific mortality over time,1,2,15"17,19"20 and many factors have been put forward to explain the observed changes.
Ewertz and Kjaer16 suggested that changes in parity between different birth cohorts of women could explain some of the observed variation in Danish ovarian cancer mortality rates. Recently, Dos Santos Silva and Swerdlow23 confirmed this hypothesis in their study of trends in incidence and mortality from breast, ovarian, In 1954, ovarian cancer was the underlying cause of and endometrial cancers in England and Wales. In their death of 443 Dutch women. This number has steadily study, the marked decrease in family size was paral leled by an increase in the risk of ovarian cancer for successive birth cohorts born before 1920. In the Neth- decreased since the beginning of this century ( Figure 3 ). There was a temporary increase just after World War II, but the number of live births has decreased further and stabilized in recent years. Therefore, the increase in ovarian cancer mortality in the oldest age groups (bom around the turn of the century) may in part be attrib uted to their declining parity. This decrease in the number of live births is accompanied by an increase in the number of nulliparous women in the period 1945-1970.3° It is not clear how this lower parity and higher number of nulliparous women in the Dutch population will affect the ovarian cancer risk of younger birth cohorts. Moreover, one should be aware of the so-called "ecologic fallacy/7 which implies that caution should be exercised when inferences are made from observed trends in population statistics because the apparent relationship may not hold on an individual level. Dos Santos Silva and Swerdlow23 also found an inverse relationship between the number of women using OCs and the risk of ovarian cancer. This relation ship had already been observed earlier by Villard- the blood gonadotropin levels, which might decrease the risk of ovarian cancer, according to the gonado tropin hypothesis put forward by StadeL41 Therefore, definitive conclusions about the effect on ovarian cancer risk of hormone replacement therapy cannot be drawn. Whittemore et al9"11 suggested ovarian stimulation for in vitro fertilization could increase the risk of ovarian cancer. Recently, Venn et al42 reported an increase in ovarian cancer risk after ovarian stimulation for in vitro fertilization in a cohort of 10,358 Australian women. Although the number of cases in this large study was very small (n = 6), which limits the conclu sions that can be drawn, this finding supports the hypothesis of Whittemore et al. However, it is doubtful whether IVF has a large impact on population incidence and mortality even if the hypothesis is true. Further research into this matter is indicated.
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Apart from the more widespread use of OCs as a potential explanation of the decline in ovarian cancer mortality rates in the younger age groups, Ayiomamitis et al19 suggested that earlier diagnoses and earlier and better treatment in the young could explain the ob served change. Furthermore, they suggested that older women are treated less aggressively and/or respond less effectively to therapy compared with younger women, as suggested earlier by Yancik et al. 37 This difference in treatment over age was affirmed by Ries,38 who investigated treatment information of more than 20,000 women diagnosed during 1973-1987 in the United States. This could apply to the situation in the Netherlands, because we have no indication that sys tematic differences exist with other countries in thera peutic decisions or patient response to treatment. Also, a more accurate death certification and registration is suggested as an explanation for the increase in mortal ity in older age groups.19 Indeed, since 1954, techniques in pathology have emerged, but it is uncertain whether this explanation holds for the increase visible in recent years as well.
The influence of changes in oophorectomy rates in the Netherlands should also be considered in this regard. Data obtained from the annual reports of the National Medical Register in the Netherlands show that oophorectomy rates increased steadily to 130 per 105 woman-years in the early 1980s but declined to less then 85 per 105 woman-years in 1990. The influence of these changes in oophorectomy rates on age-specific ovarian cancer mortality is difficult to estimate in more detail because we have no information about the age distribution of these patients. Nevertheless, these changes seem difficult to reconcile with the onset of the decrease in ovarian cancer mortality in the younger age groups. The increase in the older age groups might have contributed in part to the changes in oophorectomy rates. But similar analysis regarding the influence of changing hysterectomy rates on cervical cancer mortal ity in the Netherlands have shown that this contribution is estimated to be about 6% of the observed change. 39 Another suggested reason for the increase in ovarian cancer mortality in the elderly is the increased use of estrogen replacement therapy in peri-and postmeno pausal women.40 Indeed the use of estrogens by elderly women to prevent osteoporosis and other climacteric and menopausal complaints is increasing. And al though the normal dose of estrogen has decreased since the 1970s and the composition of the medication used
